Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#21 / 200 Total
MNDY - Monday.Com Ltd - Stock Price Chart
TickerMNDY [NASD]
CompanyMonday.Com Ltd
CountryIsrael
IndustrySoftware - Application
Market Cap10.80BEPS (ttm)0.37
P/E589.06EPS this Y24.12%
Forward P/E76.80EPS next Y25.17%
PEG-EPS past 5Y64.20%
P/S13.77EPS next 5Y-
P/B12.62EPS Q/Q144.46%
Dividend-Sales Q/Q33.69%
Insider Own28.76%Inst Own75.57%
Insider Trans0.00%Inst Trans-1.85%
Short Float6.38%EarningsMay 15/b
Analyst Recom1.53Target Price245.51
Avg Volume777.37K52W Range122.13 - 239.22
monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.
TSHA - Taysha Gene Therapies Inc - Stock Price Chart
TickerTSHA [NASD]
CompanyTaysha Gene Therapies Inc
CountryUSA
IndustryBiotechnology
Market Cap581.63MEPS (ttm)-1.16
P/E-EPS this Y59.00%
Forward P/E-EPS next Y-17.37%
PEG-EPS past 5Y-137.69%
P/S41.08EPS next 5Y-
P/B10.80EPS Q/Q62.67%
Dividend-Sales Q/Q-27.52%
Insider Own21.84%Inst Own63.62%
Insider Trans0.25%Inst Trans-1.76%
Short Float11.57%EarningsMay 14/a
Analyst Recom1.10Target Price6.95
Avg Volume2.88M52W Range0.50 - 3.89
Taysha Gene Therapies, Inc.is a patient-centric, clinical-stage gene therapy company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing. The company was founded by Steven Gray, Berge Minassian, and R. A. Session II in 2019 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Manning Paul B10% OwnerNov 17 '23Buy1.63100,000163,00016,566,667Nov 20 07:35 AM
Alam KamranChief Financial OfficerAug 24 '23Sale2.3333,00076,890258,042Aug 25 04:30 PM
Manning Paul B10% OwnerAug 16 '23Buy0.9016,466,66714,820,00016,466,667Aug 16 08:57 PM
Nolan Sean P.Chief Executive OfficerAug 16 '23Buy0.90444,444400,0001,535,545Aug 16 08:52 PM
Stalfort John A IIIDirectorAug 16 '23Buy0.90388,889350,000999,381Aug 16 08:53 PM
FUFU - BitFuFu Inc. - Stock Price Chart
TickerFUFU [NASD]
CompanyBitFuFu Inc.
CountrySingapore
IndustryCapital Markets
Market Cap17.80MEPS (ttm)0.16
P/E20.97EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.62EPS Q/Q-18.57%
Dividend-Sales Q/Q-
Insider Own55.57%Inst Own43.77%
Insider Trans0.00%Inst Trans-0.02%
Short Float4.00%EarningsMay 20/b
Analyst Recom-Target Price-
Avg Volume261.58K52W Range2.32 - 18.32
BitFuFu Inc. is a crypto-mining industry engages in the provision of digital asset mining and cloud-mining services. It offers mining rig hosting and rental, custom institution services, and miner sales. The company was founded in December 2020 and is headquartered in Singapore.
LICN - Lichen China Ltd - Stock Price Chart
TickerLICN [NASD]
CompanyLichen China Ltd
CountryChina
IndustrySpecialty Business Services
Market Cap40.50MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-78.21%
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own51.56%Inst Own0.10%
Insider Trans0.00%Inst Trans-
Short Float3.22%Earnings-
Analyst Recom-Target Price-
Avg Volume1.03M52W Range0.50 - 2.64
Lichen China Ltd. engages in providing financial and taxation solutions. It also offers educational support, and software and maintenance services. The company was founded by Li Ya on April 13, 2016 and is headquartered in Jinjiang, China.
HMNF - HMN Financial Inc. - Stock Price Chart
TickerHMNF [NASD]
CompanyHMN Financial Inc.
CountryUSA
IndustryBanks - Regional
Market Cap103.69MEPS (ttm)1.29
P/E17.97EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-4.36%
P/S1.93EPS next 5Y-
P/B0.95EPS Q/Q-19.38%
Dividend1.38%Sales Q/Q17.44%
Insider Own18.45%Inst Own60.57%
Insider Trans0.00%Inst Trans0.16%
Short Float0.12%Earnings-
Analyst Recom-Target Price-
Avg Volume3.36K52W Range17.60 - 24.95
HMN Financial, Inc. is a stock savings bank holding company which operates retail banking and loan production facilities in Minnesota, Iowa, and Wisconsin. The firm's business involves attracting deposits from the general public and businesses and using such deposits to originate or purchase single family residential, commercial real estate and multi-family mortgage loans as well as consumer, construction and commercial business loans. It also invests in mortgage-backed and related securities, U.S. government agency obligations, and other permissible investments. The company was founded in 1994 and is headquartered in Rochester, MN.
TLPH - Talphera Inc. - Stock Price Chart
TickerTLPH [NASD]
CompanyTalphera Inc.
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap20.64MEPS (ttm)-0.89
P/E-EPS this Y37.47%
Forward P/E-EPS next Y-3.72%
PEG-EPS past 5Y39.67%
P/S31.76EPS next 5Y-
P/B1.26EPS Q/Q78.63%
Dividend-Sales Q/Q-
Insider Own3.83%Inst Own39.36%
Insider Trans1.56%Inst Trans2.77%
Short Float0.90%EarningsMay 14/a
Analyst Recom1.00Target Price4.42
Avg Volume87.91K52W Range0.43 - 1.61
Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Angotti Vincent J.Chief Executive OfficerDec 13 '23Buy0.7310,0007,268101,805Dec 14 08:11 AM
Angotti Vincent J.Chief Executive OfficerSep 11 '23Buy0.8010,0007,95091,805Sep 11 07:13 PM
Palmer Pamela PChief Medical OfficerAug 25 '23Sale1.097,4428,10430,753Aug 25 04:45 PM
Palmer Pamela PChief Medical OfficerAug 24 '23Sale1.179,51411,13138,195Aug 25 04:45 PM
TMCI - Treace Medical Concepts Inc - Stock Price Chart
TickerTMCI [NASD, RUT]
CompanyTreace Medical Concepts Inc
CountryUSA
IndustryMedical Devices
Market Cap368.96MEPS (ttm)-0.89
P/E-EPS this Y-11.61%
Forward P/E-EPS next Y6.94%
PEG-EPS past 5Y-70.68%
P/S1.88EPS next 5Y-
P/B2.92EPS Q/Q-31.91%
Dividend-Sales Q/Q21.12%
Insider Own26.90%Inst Own65.74%
Insider Trans5.85%Inst Trans10.85%
Short Float6.71%EarningsMay 07/a
Analyst Recom2.71Target Price8.42
Avg Volume871.41K52W Range3.92 - 27.70
Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Treace John T.Chief Executive OfficerMay 14 '24Buy5.12150,000767,8056,243,095May 14 06:19 PM
Kiernan Jane EDirectorMay 14 '24Buy5.1719,356100,00124,941May 14 06:20 PM
Treace John T.Chief Executive OfficerMay 13 '24Buy4.56150,000683,4906,093,095May 13 06:07 PM
TREACE JAMES TDirectorMay 13 '24Buy4.54145,000657,9811,039,441May 13 07:47 PM
MOTT RICHARD WDirectorMay 13 '24Buy4.3836,802161,0901,027,753May 13 07:48 PM
BCRX - Biocryst Pharmaceuticals Inc. - Stock Price Chart
TickerBCRX [NASD, RUT]
CompanyBiocryst Pharmaceuticals Inc.
CountryUSA
IndustryBiotechnology
Market Cap1.31BEPS (ttm)-1.07
P/E-EPS this Y47.50%
Forward P/E-EPS next Y42.00%
PEG-EPS past 5Y-3.73%
P/S3.69EPS next 5Y44.80%
P/B-EPS Q/Q39.31%
Dividend-Sales Q/Q34.87%
Insider Own3.68%Inst Own82.91%
Insider Trans2.06%Inst Trans-1.64%
Short Float16.92%EarningsMay 06/b
Analyst Recom1.33Target Price14.00
Avg Volume3.38M52W Range4.03 - 8.96
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Doyle AnthonyChief Financial OfficerMay 14 '24Buy5.5736,300202,191266,744May 15 07:19 AM
Thackray Helen M.Chief R&D OfficerMay 14 '24Buy5.8630,000175,800272,139May 15 07:17 AM
Stonehouse Jon PPresident & CEOMay 13 '24Buy5.5530,000166,5001,127,770May 15 07:08 AM
Gayer Charles KChief Commercial OfficerMay 13 '24Buy5.4730,000164,100307,533May 15 07:04 AM
Galson Steven KDirectorMay 13 '24Buy5.4921,940120,45151,551May 15 07:14 AM
PSTX - Poseida Therapeutics Inc - Stock Price Chart
TickerPSTX [NASD, RUT]
CompanyPoseida Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap335.38MEPS (ttm)-1.18
P/E-EPS this Y-8.94%
Forward P/E-EPS next Y-20.44%
PEG-EPS past 5Y-12.83%
P/S4.07EPS next 5Y2.70%
P/B3.96EPS Q/Q43.86%
Dividend-Sales Q/Q172.09%
Insider Own29.83%Inst Own47.95%
Insider Trans0.00%Inst Trans56.79%
Short Float8.89%EarningsMay 14/a
Analyst Recom1.00Target Price14.00
Avg Volume695.56K52W Range1.54 - 4.27
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.
HGAS - Global Gas Corp - Stock Price Chart
TickerHGAS [NASD]
CompanyGlobal Gas Corp
CountryUSA
IndustrySpecialty Chemicals
Market Cap12.11MEPS (ttm)-0.07
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-108.78%
Dividend-Sales Q/Q-
Insider Own86.27%Inst Own15.01%
Insider Trans0.00%Inst Trans37.70%
Short Float3.19%Earnings-
Analyst Recom-Target Price-
Avg Volume93.76K52W Range1.05 - 10.66
Global Gas Corporation engages in the development and supply of nascent pure-play hydrogen, carbon and industrial gas. The company was Founded in 1989 and is headquartered in New York, NY.
123456781020